Browsing: FDA

Prostate Cancer Risk Test Receives FDA Approval; 23andMe Announces New Mutation Test 23andMe’s Prostate Cancer Risk Test has received FDA approval to focus on testing and availability in various locations, particularly as it focuses on the new mutation. According to researchers and 23andMe, a new mutation that puts men at higher risk for the cancer can be seen on the test, which will help experts learn more about it and prevent it. The FDA approves 23andMe’s prostate cancer risk test. According to a press release from 23andMe, the company has applied for FDA clearance for its Prostate Cancer Risk test,…